fingolimod hydrochloride has been researched along with Dermatitis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abels, C; Soeberdt, M | 1 |
| Chiba, K; Fukunari, A; Kataoka, H; Maeda, Y; Seki, N; Sugahara, K; Takemoto, K; Utsumi, H | 1 |
| Bonder, CS; Dimasi, DP; Grimbaldeston, MA; Heddle, R; Pitman, MR; Pitson, SM; Sun, WY; Zhuang, Y | 1 |
| Fujita, T; Inoue, M; Iwatsuki, R; Kohno, T; Tsuji, T; Yoshida, Y | 1 |
4 other study(ies) available for fingolimod hydrochloride and Dermatitis
| Article | Year |
|---|---|
Can we teach old drugs new tricks?-Repurposing of neuropharmacological drugs for inflammatory skin diseases.
Topics: Acetamides; Administration, Cutaneous; Algorithms; Anti-Inflammatory Agents; Cannabidiol; Dermatitis; Dermatologic Agents; Drug Evaluation, Preclinical; Drug Repositioning; Fingolimod Hydrochloride; Humans; Keratinocytes; Minoxidil; Neurosecretory Systems; Pyrrolidines; Sebaceous Glands; Skin | 2019 |
IL-17-Producing Vγ4+ γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions.
Topics: Animals; Cell Movement; Dermatitis; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Fingolimod Hydrochloride; Homeostasis; Immunosuppressive Agents; Inflammation; Interleukin-17; Lymph Nodes; Male; Mice; Proprotein Convertases; Receptors, Antigen, T-Cell, gamma-delta; Receptors, Lysosphingolipid; Serine Endopeptidases; T-Lymphocyte Subsets; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2015 |
Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
Topics: Administration, Topical; Animals; Capillary Permeability; Cell Movement; Cells, Cultured; Cytokines; Dermatitis; Disease Models, Animal; Fingolimod Hydrochloride; Histamine; Humans; Immunoglobulin E; Inflammation Mediators; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiple Sclerosis; Neutrophils; Phosphotransferases (Alcohol Group Acceptor); Skin | 2016 |
Therapeutic approach to steroid-resistant dermatitis using novel immunomodulator FTY720 (Fingolimod) in combination with betamethasone ointment in NC/Nga mice.
Topics: Animals; Ascomycota; Betamethasone; Biological Products; Dermatitis; Drug Resistance; Epidermis; Fingolimod Hydrochloride; Glucocorticoids; Hypertrophy; Immunologic Factors; Male; Mast Cells; Mice; Mice, Inbred Strains; Phytotherapy; Propylene Glycols; Sphingosine; Steroids; Treatment Outcome | 2012 |